However, accumulated evidence now supports the efficacy of ovarian protection using gonadotropin-releasing hormone (GnRH) agonists during chemotherapy to prevent chemotherapy-related amenorrhea or early menopause and also to preserve fertility for future pregnancies (8–12). The gene discussed is GNRH1; the disease is amenorrhea.